INSIGHTS ON DRUG DEVELOPMENT
-
Analytical Tools To Address The Development Of GLP-1 Receptor Agonists
GLP-1 receptor agonists are revolutionizing therapeutics beyond diabetes. Explore analytical innovations that ensure safety and efficacy as these peptides expand into multiple treatments.
-
Modular Facilities With Smaller Footprint Through Dynamic Perfusion
Discover how a top CDMO leveraged dynamic perfusion technology to boost biomanufacturing throughput, cut capital costs, and enable flexible, multi-modality production.
-
Monolithic Columns As Downstream Processing Solutions For Lentiviral Purification
Third-generation lentiviral vectors enable efficient gene delivery, but purification challenges limit in vivo applications. Monolithic columns and advanced assays show promise for downstream processes.
-
Improving The Efficiency And Quality Of Advanced Imaging And Analysis
Human-relevant models are transforming drug screening. Find out how overcoming 3D cell culture challenges with integrated innovations accelerates discovery and brings effective treatments to patients faster.
-
Producing Therapeutic Cardiomyocytes From iPSC Stem Cells4/29/2024
Experts from Albumedix and Heartseed show how they navigated challenges on the path to commercialization and successfully advanced a promising cardiomyocyte therapy to clinical trials.
-
Innovative Technology For Developing, Scaling Peptide-Based Therapeutics11/18/2024
Watch as experts walk through several technologies and case studies, focusing on liquid-phase peptide synthesis, crystallization, method development for impurity analysis, and more.
-
A Pre-Clinical Study For Diet-Induced Obesity3/28/2025
Here, we look at the importance of using high-fat diet-induced obesity models to evaluate and compare the efficacy of anti-obesity and anti-diabetic treatments like rimonabant and liraglutide.
-
Genome Editing Using mRNA-Lipid Nanoparticles For CAR T Cell Therapy11/22/2023
Gene delivery platforms must support a diversity of genetic engineering strategies for genomic medicine development. Learn how lipid nanoparticles can accelerate development from discovery to scale-up.
-
Scaling Up Your Methods With USP <621> - Part 1: Chemistry9/22/2023
Explore the latest updates to the USP <621> guidelines that involve changes to the allowable modifications to gradient methods and updates to system suitability parameters.
DRUG DEVELOPMENT SOLUTIONS
-
Leica DM2000
With their sophisticated modular design and high-performance fluorescence, the Leica DM2000 microscopes are ideal for complex tasks in pathology, cytology, and many other applications. For special diagnostics requirements, the microscope is certified for in-vitro-diagnostics (IVD) like in-vitro-fertilization (IVF).
-
Off-the-shelf, research use only lipid nanoparticle (LNP) reagents to deliver RNA into T-cells.
-
As part of Stevanato Group’s commitment to R&D, our analytical testing facilities focus on investigating physico-chemical properties of primary packaging materials and components and studying the interactions between container closure system and drugs. Stevanato Group relies on a multi-disciplinary team of highly skilled professionals, including, scientists, engineers, pharmaceutical chemists and biotechnologists. Their knowledge and experience covers a range of specialized areas including container closure systems and drug-delivery devices.
-
Malvern 2000 Laser Diffraction Particle Size Analyzer with (1) Malvern Model Scirocco 2000, Dry Power Tray Sampler, and (1) Malvern Model Hydro 2000S, Liquid Test Module.
-
Diabetes is a chronic metabolic disorder characterized by elevated blood glucose levels due to inadequate insulin production or impaired insulin utilization, commonly known as insulin resistance.